A CLINICAL PRACTICE GUIDELINE DEVELOPED BY CANCER AUSTRALIA
This guideline was first published in November 2011 and has been updated to incorporate new evidence.
Purpose
This guideline includes statements, recommendations and practice points based on available, high-level evidence about the use of hypofractionated radiotherapy for the treatment of women with early (operable) breast cancer. The guideline aims to provide all health professionals within a multi-disciplinary team with information to assist in making management recommendations for improved patient outcomes.
September 2015
| Incorporates published evidence to September 2014
Document Satus: Greater than 5 years
This resource was developed, reviewed or revised more than 5 years ago and may no longer reflect current evidence or best practice.
This resource was developed, reviewed or revised more than 5 years ago and may no longer reflect current evidence or best practice.
Table of Contents
© Cancer Australia 2015
Endorsed by:
